T Cell News and Research

Latest T Cell News and Research

Mitochondrial dysfunction linked to chemotherapeutic resistance in African-American men with prostate cancer

Improper functioning of the mitochondria, a cell's source of energy, may help account for the fact that African-American men with prostate cancer respond poorly to the same conventional therapies provided to Caucasian-American men, according to research led by Dhyan Chandra, PhD, Associate Professor of Oncology in the Department of Pharmacology and Therapeutics at Roswell Park Cancer Institute.

30 Apr 2016

NCCN publishes series of patient education materials for Non-Hodgkin's Lymphoma

It is estimated that more than 72,000 people in the United States will be diagnosed with Non-Hodgkin's Lymphomas (NHL) in 2016. The sixth leading cancer diagnosis in U.S. men and women, NHL has more than 30 sub-types, each featuring unique treatment choices and challenges.

30 Apr 2016

Novel method may enable quick, easy exhaustive analysis of ORs responding to specific odorants

A research group led by Osaka University and Panasonic Corporation developed a method for making a prompt, exhaustive isolation of olfactory receptors (ORs) responding to the odorant of interest. This achievement will enable quick and easy exhaustive analysis of ORs responding to specific odorants, which previously required a great deal of time and effort. These results may be applied to biosensors capable of highly detecting only desired odorants.

30 Apr 2016

New article reviews ability of different stem cells to help restore function after spinal cord injuries

Stem cell therapy is a rapidly evolving and promising treatment for spinal-cord injuries. According to a new literature review, published in the April issue of the Journal of the American Academy of Orthopedic Surgeons, different types of stem cells vary in their ability to help restore function, and an ideal treatment protocol remains unclear pending further clinical research.

30 Apr 2016

Elusive brain receptor may play vital role in death of neurons from neurological diseases

Strokes, seizures, traumatic brain injury and schizophrenia: these conditions can cause persistent, widespread acidity around neurons in the brain. But exactly how that acidity affects brain function isn't well understood.

30 Apr 2016

Female hormones may be responsible for decreased risk of kidney failure in women than men

Female hormones may play a role in women's decreased risk of developing kidney failure relative to men, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology. The findings may be helpful for future attempts at safeguarding women's and men's kidney health in sex-specific ways.

29 Apr 2016

Scientists measure electrical activity of individual brain cells responsible for body recognition

Specific regions of the brain are specialized in recognizing bodies of animals and human beings. By measuring the electrical activity per cell, scientists from KU Leuven, Belgium, and the University of Glasgow have shown that the individual brain cells in these areas do different things. Their response to specific contours or body shapes is very selective.

29 Apr 2016

Predictive statistical approach opens door to development of more effective therapies for breast cancer

Designing effective new drugs, especially drugs to fight cancer, demands that you know as much as you can about the molecular workings of cancer growth. Without that, it's like planning to fight a war against an enemy you've never seen.

29 Apr 2016

Scientists find way to reduce need for secondary cataract surgery

Scientists at the University of East Anglia may have found a way to prevent complications from surgery to treat cataract - the world's leading cause of blindness.

29 Apr 2016

TJP1 protein could help determine multiple myeloma patients who may best benefit from proteasome inhibitors

A gene known as TJP1 (tight junction protein 1) could help determine which multiple myeloma patients would best benefit from proteasome inhibitors such as bortezomib, as well as combination approaches to enhance proteasome inhibitor sensitivity, according to a study led by The University of Texas MD Anderson Cancer Center.

29 Apr 2016

Curve along edge of tumor may play major role in cancer cell metastasis

Only a few cells in a cancerous tumor are able to break away and spread to other parts of the body, but the curve along the edge of the tumor may play a large role in activating these tumor-seeding cells, according to a new University of Illinois study.

29 Apr 2016

New research on EdnrB, Wnt signaling pathways could lead to therapies for skin pigment disorders

A pair of molecular signals controls skin and hair color in mice and humans — and could be targeted by new drugs to treat skin pigment disorders like vitiligo, according to a report by scientists at NYU Langone Medical Center.

29 Apr 2016

Understanding how individuals respond to aspirin

Researchers have learned new information about how different people respond to aspirin, a globally prescribed drug in cardioprotection. The research team, led by scientists at Cardiff University in the United Kingdom and including representatives from the University of Alabama at Birmingham and the University of Colorado, identified more than 5,600 lipids — or fats — in blood platelets and gained new insights into how these cells respond to aspirin.

29 Apr 2016

Pioneering gene therapy may lead to potential cure for common causes of vision loss

Pioneering gene therapy has restored some vision to patients with a rare form of genetic blindness for as long as four years, raising hopes it could be used to cure common causes of vision loss, new University of Oxford research published today shows.

29 Apr 2016

Discovery of shared biological properties among DNA variants may help identify new therapeutic targets

The discovery of shared biological properties among independent variants of DNA sequences offers the opportunity to broaden understanding of the biological basis of disease and identify new therapeutic targets, according to a collaboration between the Perelman School of Medicine at the University of Pennsylvania, the University of Arizona Health Sciences, and Vanderbilt University. The group published their findings this month in npj Genomic Medicine.

29 Apr 2016

Gut bacteria linked to risk of bloodstream infections after chemotherapy

A new study led by researchers at the University of Minnesota and Nantes University Hospital in France shows that the bacteria in people's gut may predict their risk of life-threatening blood infections following high-dose chemotherapy.

29 Apr 2016

Key gene changes reveal four previously unknown conditions within schizophrenia

Changes in key genes clearly define four previously unknown conditions within the umbrella diagnosis of schizophrenia, according to a study led by researchers from NYU Langone Medical Center published online April 28 in EBioMedicine, a Lancet journal. Cases associated with changes in each of the four genes were different from each other in terms of symptoms, intelligence level and other disease features.

29 Apr 2016

Dopamine neuron transplants controlled by designer drug may fight Parkinson's disease in mice

A University of Wisconsin-Madison neuroscientist has inserted a genetic switch into nerve cells so a patient can alter their activity by taking designer drugs that would not affect any other cell. The cells in question are neurons and make the neurotransmitter dopamine, whose deficiency is the culprit in the widespread movement disorder Parkinson's disease.

29 Apr 2016

New fluorescent chemical probes that measure enzyme levels can diagnose inherited genetic disorders

Scientists at the Universities of York and Leiden have made a significant breakthrough in the treatment of an inherited genetic disorder which damages muscle and nerve cells in the body.

29 Apr 2016

Janssen gets positive CHMP opinion for IMBRUVICA (ibrutinib) to treat patients with previously untreated CLL

Janssen-Cilag International NV today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a Positive Opinion, recommending broadening the existing marketing authorisation for ibrutinib as a single agent for the treatment of adult patients with previously untreated chronic lymphocytic leukaemia (CLL).

29 Apr 2016

T Cell News and Research

Latest T Cell News and Research

Mitochondrial dysfunction linked to chemotherapeutic resistance in African-American men with prostate cancer

NCCN publishes series of patient education materials for Non-Hodgkin's Lymphoma

Novel method may enable quick, easy exhaustive analysis of ORs responding to specific odorants

New article reviews ability of different stem cells to help restore function after spinal cord injuries

Elusive brain receptor may play vital role in death of neurons from neurological diseases

Female hormones may be responsible for decreased risk of kidney failure in women than men

Scientists measure electrical activity of individual brain cells responsible for body recognition

Predictive statistical approach opens door to development of more effective therapies for breast cancer

Scientists find way to reduce need for secondary cataract surgery

TJP1 protein could help determine multiple myeloma patients who may best benefit from proteasome inhibitors

Curve along edge of tumor may play major role in cancer cell metastasis

New research on EdnrB, Wnt signaling pathways could lead to therapies for skin pigment disorders

Understanding how individuals respond to aspirin

Pioneering gene therapy may lead to potential cure for common causes of vision loss

Discovery of shared biological properties among DNA variants may help identify new therapeutic targets

Gut bacteria linked to risk of bloodstream infections after chemotherapy

Key gene changes reveal four previously unknown conditions within schizophrenia

Dopamine neuron transplants controlled by designer drug may fight Parkinson's disease in mice

New fluorescent chemical probes that measure enzyme levels can diagnose inherited genetic disorders

Janssen gets positive CHMP opinion for IMBRUVICA (ibrutinib) to treat patients with previously untreated CLL

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in